HALO: Halozyme Therapeutics Inc
HALO exchange rate has changed by -0.92% for today. During the day, the instrument was traded at a low of 68.1200 and at a high of 69.4800.
Follow Halozyme Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
HALO News
- Benchmark raises Halozyme stock price target to $90 on strong results
- Monster Beverage, Other 'Gold Medal' Level Stocks Hit Record Highs, Join Best Stock Lists
- Stock Market Today: Dow Up 300 Points Amid Bullish Breadth; Amer Sports Glows In Breakout (Live Coverage)
- Halozyme's Q4 Earnings Miss, Higher Royalties Drive Y/Y Revenues
- Halozyme Delivers Record FY2025 As 2026 Sets Up A Major Profitability Surge (NASDAQ:HALO)
- TD Cowen raises Halozyme stock price target on royalty growth
- Halozyme Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:HALO) 2026-02-18
- Dow Jones Futures Fall After Market Reverses Higher; Meta Deal Lifts Nvidia, Hits AI Rivals
- Halozyme Therapeutics, Inc. (HALO) Q4 2025 Earnings Call Transcript
- Here's What Key Metrics Tell Us About Halozyme Therapeutics (HALO) Q4 Earnings
- Halozyme Therapeutics (HALO) Reports Q4 Loss, Tops Revenue Estimates
- Halozyme earnings missed by $2.14, revenue topped estimates
- Halozyme shares fall 4% following surprise Q4 loss
- Halozyme earnings in focus: Can royalty momentum carry into 2026?
- Here's Why Halozyme Therapeutics (HALO) is a Strong Momentum Stock
- Here's How Much a $1000 Investment in Halozyme Therapeutics Made 10 Years Ago Would Be Worth Today
- Stay Ahead of the Game With Halozyme Therapeutics (HALO) Q4 Earnings: Wall Street's Insights on Key Metrics
- Earnings Preview: BioMarin Pharmaceutical (BMRN) Q4 Earnings Expected to Decline
- Halozyme Therapeutics (HALO) to Report Q4 Results: Wall Street Expects Earnings Growth
- Halozyme, Other Hot Medical Plays Lead 22 Stocks Onto Best Stock Lists Like IBD 50, IPO Leaders
- This Medical Technology Leader Sees Growth Into The 2040s
- Eli Lilly Heads Group Of 17 Hot Prospects Joining IBD 50, Stock Spotlight, Other Best Stock Lists
- Dow Jones Leader Cisco, Halozyme, Toll Brothers In Or Near Buy Zones
- Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term
Frequently Asked Questions
What is HALO stock price today?
Halozyme Therapeutics Inc stock is priced at 69.2100 today. It trades within 68.1200 - 69.4800, yesterday's close was 69.8500, and trading volume reached 891. The live price chart of HALO shows these updates.
Does Halozyme Therapeutics Inc stock pay dividends?
Halozyme Therapeutics Inc is currently valued at 69.2100. Dividend policy depends on the company, while investors also watch 3.61% and USD. View the chart live to track HALO movements.
How to buy HALO stock?
You can buy Halozyme Therapeutics Inc shares at the current price of 69.2100. Orders are usually placed near 69.2100 or 69.2130, while 891 and 1.08% show market activity. Follow HALO updates on the live chart today.
How to invest into HALO stock?
Investing in Halozyme Therapeutics Inc involves considering the yearly range 61.2250 - 82.2200 and current price 69.2100. Many compare 1.30% and 3.61% before placing orders at 69.2100 or 69.2130. Explore the HALO price chart live with daily changes.
What are Halozyme Therapeutics Inc stock highest prices?
The highest price of Halozyme Therapeutics Inc in the past year was 82.2200. Within 61.2250 - 82.2200, the stock fluctuated notably, and comparing with 69.8500 helps spot resistance levels. Track Halozyme Therapeutics Inc performance using the live chart.
What are Halozyme Therapeutics Inc stock lowest prices?
The lowest price of Halozyme Therapeutics Inc (HALO) over the year was 61.2250. Comparing it with the current 69.2100 and 61.2250 - 82.2200 shows potential long-term entry points. Watch HALO moves on the chart live for more details.
When did HALO stock split?
Halozyme Therapeutics Inc has gone through stock splits historically. These changes are visible in , 69.8500, and 3.61% after corporate actions.
- Previous Close
- 69.8500
- Open
- 68.4700
- Bid
- 69.2100
- Ask
- 69.2130
- Low
- 68.1200
- High
- 69.4800
- Volume
- 891
- Daily Change
- -0.92%
- Month Change
- 1.30%
- 6 Months Change
- 3.61%
- Year Change
- 3.61%